simon

I literally have an ongoing cancer experiment where 100% of the untreated and control animals have had to be euthanized while 100% of the treatment animals are seemingly unaffected. But we're still extremely far away from "proving that it works." Science is hard.

found a use case

eh kinda, here's our stripes from june 2025 got a random cold call from some woman asking about numbers and told her some bs, did not expect an article about it here's what we were doing at the time: > consumer arr 2.7m, run rate 3.8m > enterprise arr 2.5m, run rate 2.5m > total 5.2m arr, 6.3m run rate this is the only blatantly dishonest thing i've said publicly online, so this is my formal retraction myb, tech crunch foid we're profitable btw

Cloning any random piece of SaaS is something that could already be done before agentic coding, and the economics of it haven't changed meaningfully. Before, writing the clone would cost 0.5-1% of the valuation of the legacy SaaS company. Now it might be 0.1%. It doesn't make a difference -- if you can pull it off profitably today you could also have done it profitably in the past. The code is a very small part of the process of making such a clone successful, and the reason legacy software has often bad UX is not because code was expensive to write.